HCPLive Network

HIV-Risk Behaviors Stable for U.S. High School Students

Wednesday, July 25 (HealthDay News) -- Using data from the CDC's National Youth Risk Behavior Surveys from 1991 to 2001, Laura Kann, Ph.D., from the CDC in Atlanta, and colleagues examined trends overall and by race/ethnicity for HIV-related risk behavior among U.S. high school students.

The researchers found that, through the early 2000s, sexual risk behaviors declined among U.S. high school students, but progress subsequently stalled. From 1991 to 2001 there was a decrease in the proportion of U.S. high school students who had ever had sex (54 to 46 percent) or had had multiple partners (four or more; 19 to 14 percent); there was an increase in the proportion of students who used a condom last time they had sex (from 46 percent in 1991 to 63 percent in 2003). These proportions stabilized and were 47, 15, and 60 percent, respectively, in 2011. There was also a decrease in the proportion of students who had had sex within the preceding three months, from 38 percent in 1991 to 34 percent in 2011.

"Protecting the health of young people and accelerating progress in HIV prevention in this population will require building upon these and other efforts in homes, schools, and communities across the nation," the authors write. "Only by intensifying our collective efforts will we be able to achieve our shared goal of an AIDS-free generation."

Full Text
More Information

Although there were reductions in HIV-related risk behavior among U.S high school students from 1991 to the early 2000s, behaviors have subsequently stabilized, according to research published in the June 24 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report to coincide with the International AIDS Conference, held from July 22 to 27 in Washington, D.C.

Copyright © 2012 HealthDay. All rights reserved.


Further Reading
The CDC has deemed the 2014-2015 flu season as reaching epidemic proportions. In part 2 of our flu series interview with Rob Pedowitz, DO, from CentraState Healthcare System, discusses what makes it an epidemic as well as issues with the current flu vaccine.
The US Food and Drug Administration approved ferric pyrophosphate citrate (Triferic/Rockwell) for use as an iron replacement therapy in patients with end-stage renal disease, the company announced. It is also indicated for chronic kidney disease. The drug is for adults.
In the past few months patients diagnosed with Hepatitis C have seen what had been terminal conditions be cured. The technology used to find these curative treatments can now be applied to other conditions.
More Reading